Why the study?
Does combination therapy with diltiazem and propranolol precipitate congestive heart failure in patients with baseline left ventricular dysfunction?
Does combination therapy with diltiazem and propranolol precipitate congestive heart failure in patients with baseline left ventricular dysfunction?
Combination therapy with diltiazem and propranolol can precipitate congestive heart failure in patients with baseline left ventricular dysfunction.
May precipitate CHF with diltiazem-propranolol in reduced LVEF; hypothesis-generating case report requiring prospective confirmation.
Although congestive heart failure has been reported with the combination of a beta blocker and either verapamil or nifedipine, it has not previously been reported for combination therapy that includes diltiazem. The following case documents the occurrence of clinical congestive failure in a patient with baseline left ventricular dysfunction and severe angina pectoris. Although the patients had tolerated propranolol therapy for years without difficulty, and high-dose diltiazem monotherapy with an excellent clinical response, the combination of diltiazem and propranolol resulted in the development of congestive heart failure. Thus, although generally well tolerated, given the suitable scenario of reduced left ventricular function, the combination of diltiazem and a beta blocker may adversely affect left ventricular performance.
No takes yet. Share an insight, caveat, or question.
Strauss et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: